These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 2558829

  • 1. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E, Lane DA, Ireland H, Flynn A, Curtis JR.
    Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222.
    Ireland H, Lane DA, Flynn A, Pegrum AC, Curtis JR.
    Thromb Haemost; 1988 Apr 08; 59(2):240-7. PubMed ID: 2838924
    [Abstract] [Full Text] [Related]

  • 5. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model.
    Ao PY, Hawthorne WJ, Coombs R, Fletcher JP.
    Int Angiol; 1999 Jun 08; 18(2):131-9. PubMed ID: 10424369
    [Abstract] [Full Text] [Related]

  • 6. Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formation.
    Lane DA, Ireland H, Flynn A, Anastassiades E, Curtis JR.
    Nephrol Dial Transplant; 1986 Jun 08; 1(3):179-87. PubMed ID: 2955253
    [Abstract] [Full Text] [Related]

  • 7. Heparin induces mobilization of osteoprotegerin into the circulation.
    Vik A, Brodin E, Sveinbjørnsson B, Hansen JB.
    Thromb Haemost; 2007 Jul 08; 98(1):148-54. PubMed ID: 17598007
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis.
    Bratt G, Törnebohm E, Granqvist S, Aberg W, Lockner D.
    Thromb Haemost; 1985 Dec 17; 54(4):813-7. PubMed ID: 3911482
    [Abstract] [Full Text] [Related]

  • 10. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S, Wolz M, Nieszpaur-Los M, Schneider B, Lechner K, Eichler HG, Kyrle PA.
    Thromb Haemost; 1994 Dec 17; 72(6):831-5. PubMed ID: 7740450
    [Abstract] [Full Text] [Related]

  • 11. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
    Brodin E, Svensson B, Paulssen RH, Nordoy A, Hansen JB.
    J Lab Clin Med; 2004 Nov 17; 144(5):246-53; discussion 226-7. PubMed ID: 15570242
    [Abstract] [Full Text] [Related]

  • 12. [Appropriate dosage of unfraction heparin and low molecular weight heparin in hemodialysis patients].
    Xiao Q, Sun XF, Zhang D, Ma ZF, Wu MG, Wang H, Chen XM.
    Zhonghua Yi Xue Za Zhi; 2010 Jan 19; 90(3):187-91. PubMed ID: 20356555
    [Abstract] [Full Text] [Related]

  • 13. [Prevention of thrombogenesis in the extracorporeal circuit of hemodialysis with a low molecular heparin: standardization of the dosage with a better hemorrhagic risk/effectiveness ratio].
    Barata JD, Oliveira C, Bruges M, Gusmão L, Santana A, Ponce P, Simões J, Freire I, Crespo F, da Silva AN.
    Acta Med Port; 1992 Feb 19; 5(2):65-70. PubMed ID: 1317657
    [Abstract] [Full Text] [Related]

  • 14. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.
    Grimaudo V, Omri A, Kruithof EK, Hauert J, Bachmann F.
    Thromb Haemost; 1988 Jun 16; 59(3):388-91. PubMed ID: 2847348
    [Abstract] [Full Text] [Related]

  • 15. Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction.
    Nilsen DW, Gøransson L, Larsen AI, Hetland O, Kierulf P.
    Thromb Haemost; 1997 Jan 16; 77(1):57-61. PubMed ID: 9031450
    [Abstract] [Full Text] [Related]

  • 16. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
    Gunnarsson B, Asaba H, Dawidson S, Wilhelmsson S, Bergström J.
    Clin Nephrol; 1981 Mar 16; 15(3):135-42. PubMed ID: 7273488
    [Abstract] [Full Text] [Related]

  • 17. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
    Dieval J, Morinière P, Roussel B, Bayrou B, Fournier A, Delobel J.
    J Mal Vasc; 1987 Mar 16; 12 Suppl B():114-8. PubMed ID: 2834482
    [Abstract] [Full Text] [Related]

  • 18. Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin.
    Camici M, Giordani R, Morelli E, Meriggioli M, Balestri PL, Barsotti G, Sagripanti A.
    Minerva Med; 1998 Mar 16; 89(11-12):405-9. PubMed ID: 10212664
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of low molecular weight heparin during and after aortic and carotid surgery: dose finding study.
    Alimi YS, Juhan C, Barthelemy P, Boudier JL, Pansart M, Boutin B, De Moro S.
    Panminerva Med; 1996 Mar 16; 38(1):15-21. PubMed ID: 8766874
    [Abstract] [Full Text] [Related]

  • 20. Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
    Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G.
    Arch Intern Med; 2007 Dec 10; 167(22):2423-30. PubMed ID: 18071163
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.